Gene Solutions' SPOT-MAS 10 real-world data on 84,145 patients gains ASCO spotlight
July 07, 2026 | 15:38
Gene Solutions presented real-world blood-based cancer screening data from more than 84,145 individuals at ASCO Breakthrough 2026, with the American Society of Clinical Oncology highlighting the Asia-developed SPOT-MAS 10 technology.
Mobile Version